The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now — FDA lists the reason as “other”.
Market view
sufentanil citrate · Injection, Solution
2 marketed package NDCs · 2 active manufacturers
Most dispensed: 1 g/g · Powder · #500 g/bottle, glass
Same drug class
Other molecules FDA puts in Opioid Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- morphine· in shortage
- fentanyl· in shortage
- remifentanil hydrochloride· in shortage
- meperidine hydrochloride· in shortage
- fentanyl citrate· in shortage
- hydromorphone hydrochloride· in shortage
- morphine sulfate· in shortage
- acetaminophen, caffeine, dihydrocodeine bitartrate· 1 maker
- butalbital, aspirin, cafeine, and codeine phosphate· 1 maker
- codeine phosphate and chlorpheniramine maleate· 1 maker
- codeine phosphate, dexbrompheniramine maleate· 1 maker
- fentanyl transdermal· 1 maker
Common questions
- Is Sufentanil citrate in shortage right now?
- Yes. FDA currently lists Sufentanil citrate in shortage, with the reason given as "other". This page is rebuilt every morning from FDA's shortage database.
- Who makes Sufentanil citrate?
- 7 companies have marketed Sufentanil citrate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
Shortage reports for this molecule
- In shortage now — Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21)May 3, 2022
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.